Literature DB >> 23751516

Neuronal activity-regulated pentraxin expressed in medial prefrontal cortex neurons is not necessary for extinction of heroin self-administration.

Ashley M Blouin1, Anna L Stern, Sungho Han, Florence R Theberge, Chuansong Wang, Matthew J During, Jay M Baraban, Irving M Reti.   

Abstract

The medial prefrontal cortex (mPFC) plays a key role in extinction learning. Previously, we found that expression of a neuronal activity-regulated pentraxin (Narp) dominant-negative construct in the mPFC of mice blocked extinction of morphine-conditioned place preference. To further investigate the role of mPFC Narp in the extinction of drug seeking, we tested whether mPFC Narp is necessary for the extinction of heroin self-administration in rats. Specifically, we injected an adeno-associated viral vector expressing a dominant-negative form of Narp (NarpN) into the infralimbic region of the mPFC of rats and compared lever presses during extinction to those of rats injected with a control virus. In contrast to our previous study, we found that injection of NarpN did not affect extinction of heroin self-administration. Our findings suggest that mPFC Narp is necessary for extinction of opiate seeking in the Pavlovian-conditioned place preference paradigm but not in the operant paradigm of drug self-administration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23751516      PMCID: PMC3779366          DOI: 10.1097/FBP.0b013e328363367b

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  20 in total

1.  Self-administration cues as signals: drug self-administration and tolerance.

Authors:  L Weise-Kelly; S Siegel
Journal:  J Exp Psychol Anim Behav Process       Date:  2001-04

Review 2.  Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Authors:  M T Bardo; R A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

Review 3.  Neuroadaptive effects of active versus passive drug administration in addiction research.

Authors:  Edwin H Jacobs; August B Smit; Taco J de Vries; Anton N M Schoffelmeer
Journal:  Trends Pharmacol Sci       Date:  2003-11       Impact factor: 14.819

4.  Narp deletion blocks extinction of morphine place preference conditioning.

Authors:  Hans S Crombag; Mercy Dickson; Megan Dinenna; Alexander W Johnson; Mark S Perin; Peter C Holland; Jay M Baraban; Irving M Reti
Journal:  Neuropsychopharmacology       Date:  2008-06-04       Impact factor: 7.853

5.  Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving.

Authors:  Lin Lu; Jamie L Uejima; Sarah M Gray; Jennifer M Bossert; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2006-08-07       Impact factor: 13.382

6.  Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp.

Authors:  R J O'Brien; D Xu; R S Petralia; O Steward; R L Huganir; P Worley
Journal:  Neuron       Date:  1999-06       Impact factor: 17.173

Review 7.  Animal models for assessing drugs of abuse.

Authors:  J V Brady
Journal:  Neurosci Biobehav Rev       Date:  1991       Impact factor: 8.989

8.  Synaptically targeted narp plays an essential role in the aggregation of AMPA receptors at excitatory synapses in cultured spinal neurons.

Authors:  Richard O'Brien; Desheng Xu; Ruifa Mi; Xiaopei Tang; Carsten Hopf; Paul Worley
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

9.  Cocaine seeking over extended withdrawal periods in rats: different time courses of responding induced by cocaine cues versus cocaine priming over the first 6 months.

Authors:  Lin Lu; Jeffrey W Grimm; Jack Dempsey; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

10.  Induction of the learning and plasticity-associated gene Zif268 following exposure to a discrete cocaine-associated stimulus.

Authors:  Kerrie L Thomas; Mercedes Arroyo; Barry J Everitt
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.